AOD-9604 research guide

AOD-9604 in Kohimon — Fat Loss Peptide Research Guide

AOD-9604 research guide for Kohimon. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.

Skip to Sourcing Guide Order AOD-9604 →

AOD-9604 Near Kohimon — What Researchers Need to Know

For anyone in Kohimon searching for AOD-9604, the foundational reality is that this compound is available only through an online research supply market. What this means for Kohimon researchers is that your location matters far less than your ability to verify analytical documentation — and those quality checks are accessible to anyone. The key verification criteria for AOD-9604 are HPLC purity ≥98%, molecular identity established via mass spectrometry, and a bacterial endotoxin panel — all documented in a batch-specific Certificate of Analysis. Use this guide to assess sourcing options methodically — the quality evaluation approach outlined here apply whether you are in Kohimon or anywhere else.

Understanding AOD-9604 — Biology & Evidence

AOD-9604 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Kohimon studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.

Sourcing Research-Grade AOD-9604

Before evaluating any specific vendor, establish a quality benchmark — so you can identify whether a supplier meets the standard. The HPLC chromatogram is the most important document in the COA: it should show a large primary peak representing AOD-9604, with minimal secondary peaks representing impurities — purity should be stated as ≥98%. Signs of a credible vendor beyond COA quality: multi-year operating history, responsive technical support who understand testing methodology, and shipping with desiccant and appropriate cold protection. Bacteriostatic water is the correct reconstitution medium for AOD-9604 — it contains 0.9% benzyl alcohol that suppresses bacterial proliferation and extends reconstituted shelf life to 30 days refrigerated.

Order AOD-9604 — ships to Kohimon
COA-verified · International tracking · Research grade
Order Now →

AOD-9604 Research Safety Guide

Research compound status for AOD-9604 means risk characterisation relies on animal studies, in-vitro work, and limited human observations — rather than the large-scale clinical data that informs approved drug safety. Temperature excursions — even short periods above −20°C — can partially degrade AOD-9604 without any obvious sign; always use only material shipped with appropriate cold protection. Bacterial endotoxin contamination is the most serious safety risk specific to research peptides — verify endotoxin testing is included in the batch-specific COA before any injectable research application. The research literature on AOD-9604 should be read critically before beginning any research — study designs, dosing ranges, and outcome measures vary significantly and not all findings translate directly.

Frequently Asked Questions

What is the clinical trial history of AOD-9604?

AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.

What is AOD-9604?

AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.

How does AOD-9604 differ from growth hormone?

AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.

Order AOD-9604 today
COA-verified · International shipping available
Order Now →